Goldman Sachs
PIII icon

Goldman Sachs’s P3 Health Partners PIII Stock Holding History

Goldman Sachs’s Portfolio PIII Stock Details PIII Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-238
Closed -$4.6K – 6212
2024
Q3 		$4.6K Sell
238
-9,296
-98% -$244K ﹤0.01% 5735
2024
Q2 		$215K Buy
9,534
+9,322
+4,397% +$278K ﹤0.01% 5237
2024
Q1 		$10.9K Buy
+212
New +$11.8K ﹤0.01% 5430
2023
Q4 		– Sell
-871
Closed -$64K – 5786
2023
Q3 		$64K Buy
871
+258
+42% +$26.8K ﹤0.01% 5248
2023
Q2 		$91.6K Buy
613
+279
+84% +$38.6K ﹤0.01% 5372
2023
Q1 		$17.7K Buy
+334
New +$20.1K ﹤0.01% 5681
2022
Q2 		– Sell
-203
Closed -$80K – 6647
2022
Q1 		$80K Buy
+203
New +$60.9K ﹤0.01% 6169
2021
Q4 		– Sell
-11,072
Closed -$5.46M – 6645
2021
Q3 		$5.46M Sell
11,072
-110
-1% -$54.2K ﹤0.01% 3288
2021
Q2 		$5.53M Buy
+11,182
New +$5.48M ﹤0.01% 3253

Other funds holding PIII

Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Corient Private Wealth
Corient Private Wealth Miami, Florida $78.6B AUM 28.08% 1-Year Est. Return
TFA
Trinity Financial Advisors Columbus, Ohio $389M AUM 20.97% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
WIA
Wealthedge Investment Advisors New York $294M AUM 20.18% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
AWC
Abundance Wealth Counselors State College, Pennsylvania $1.54B AUM 31.07% 1-Year Est. Return

Goldman Sachs's PIII Position: Q4 2024 in Review

Goldman Sachs sold out of P3 Health Partners (PIII) in Q4 2024, closing a stake of 238 shares — an estimated $4.6K sold.

Goldman Sachs first reported a position in PIII in Q2 2021 and held it in 9 quarters. The position peaked at $5.53M in Q2 2021. 37 funds tracked by Wall St. Rank hold PIII as of Q4 2024.

  • Goldman Sachs reported no remaining P3 Health Partners position as of Q4 2024 after selling out during the quarter.
  • Goldman Sachs sold 238 P3 Health Partners shares in Q4 2024, an estimated $4.6K.
  • Goldman Sachs first reported a position in P3 Health Partners in Q2 2021 and held it in 9 quarters.
  • Goldman Sachs's P3 Health Partners position peaked at $5.53M in Q2 2021.
  • 37 funds tracked by Wall St. Rank held P3 Health Partners as of Q4 2024.

Based on Goldman Sachs's 13F filing for Q4 2024, filed 11 Feb 2025.